• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Re: Tobias Nordström, Andrew Vickers, Melissa Assel, Hans Lilja, Henrik Grönberg, Martin Eklund. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer. Eur Urol 2015;68:139-46.回复：托拜厄斯·诺德斯特伦、安德鲁·维克斯、梅利莎·阿塞尔、汉斯·利尔亚、亨里克·格伦伯格、马丁·埃克隆德。用于预测前列腺癌的四激肽释放酶组合与前列腺健康指数的比较。《欧洲泌尿外科杂志》2015年；68卷：139 - 146页
Eur Urol. 2018 Aug;74(2):e35-e36. doi: 10.1016/j.eururo.2018.04.027. Epub 2018 May 3.
2
Re: Peter Ström, Tobias Nordström, Henrik Grönberg, Martin Eklund. The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.12.028.
Eur Urol. 2018 Jul;74(1):e9. doi: 10.1016/j.eururo.2018.03.010. Epub 2018 Mar 26.
3
Reply to Ola Bratt and Anna Öfverholm's Letter to the Editor re: Peter Ström, Tobias Nordström, Henrik Grönberg, Martin Eklund. The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.12.028.回复奥拉·布拉特和安娜·奥弗霍尔姆致编辑的信，信的内容涉及：彼得·斯特罗姆、托比亚斯·诺德斯特伦、亨里克·格伦伯格、马丁·埃克隆德。前列腺癌检测的斯德哥尔摩-3模型：算法更新、生物标志物贡献及反射试验潜力。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2017.12.028 。
Eur Urol. 2018 Jul;74(1):e10-e11. doi: 10.1016/j.eururo.2018.03.009. Epub 2018 Mar 26.
4
Re: Henrik Grönberg, Martin Eklund, Wolfgang Picker, et al. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging. Eur Urol 2018;74:722-8.
Eur Urol. 2019 Apr;75(4):e103. doi: 10.1016/j.eururo.2018.11.047. Epub 2018 Dec 4.
5
Reply to Erik Rud, Peter Lauritzen, and Eduard Baco's Letter to the Editor re: Henrik Grönberg, Martin Eklund, Wolfgang Picker, et al. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging. Eur Urol 2018;74:722-8.对埃里克·鲁德、彼得·劳里茨森和爱德华·巴科致编辑的信的回复，主题为：亨里克·格伦贝里、马丁·埃克隆德、沃尔夫冈·皮克等人。使用斯德哥尔摩3血液检测和多参数磁共振成像联合进行前列腺癌诊断。《欧洲泌尿外科杂志》2018年；74卷：722 - 728页 。
Eur Urol. 2019 Apr;75(4):e104-e105. doi: 10.1016/j.eururo.2018.11.046. Epub 2018 Dec 1.
6
Re: Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone: Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above: A. Vickers, E. A. Vertosick, D. D. Sjoberg, M. J. Roobol, F. Hamdy, D. Neal, A. Bjartell, J. Hugosson, J. L. Donovan, A. Villers, S. Zappala and H. Lilja J Urol 2017;197:607-613.回复：诊断灰色区域外的4-激肽释放酶检测组合的特性：对直肠指检阳性或前列腺特异性抗原≥10 ng/ml患者的荟萃分析：A. 维克斯、E.A. 韦尔托西克、D.D. 舍贝里、M.J. 鲁博尔、F. 哈姆迪、D. 尼尔、A. 比亚特尔、J. 胡戈松、J.L. 多诺万、A. 维勒斯、S. 扎帕拉和H. 利尔雅 《泌尿外科杂志》2017年；197卷：607 - 613页
J Urol. 2017 Aug;198(2):445-446. doi: 10.1016/j.juro.2017.03.128. Epub 2017 Apr 27.
7
Re: Johan Lindberg, Anna Kristiansen, Peter Wiklund, Henrik Grönberg, Lars Egevad. Tracking the Origin of Metastatic Prostate Cancer. Eur Urol 2015;67:819-22.回复：约翰·林德伯格、安娜·克里斯蒂安森、彼得·维克lund、亨里克·格伦伯格、拉尔斯·埃格瓦德。追踪转移性前列腺癌的起源。《欧洲泌尿外科杂志》2015年；67卷：819 - 22页。
Eur Urol. 2015 Dec;68(6):e134-5. doi: 10.1016/j.eururo.2015.07.011. Epub 2015 Jul 26.
8
Reply from Authors re: Andrew J. Vickers, Michael J. Pencina. Prostate-specific antigen velocity: new methods, same results, still no evidence of clinical utility. Eur Urol 2013;64:394-6: prostate-specific antigen velocity: new unscreened cohort, natural history of prostate cancer, room for different interpretations.
Eur Urol. 2013 Sep;64(3):396-7. doi: 10.1016/j.eururo.2013.03.049. Epub 2013 Apr 2.
9
Re: Melissa Assel, Anders Dahlin, David Ulmert, et al. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening. Eur Urol 2018;73:961-7.回复：梅利莎·阿塞尔、安德斯·达林、大卫·乌尔默特等人。铅时间与前列腺癌分级之间的关联：来自未接受前列腺特异性抗原筛查的大型人群队列长期随访的分级进展证据。《欧洲泌尿外科杂志》2018年；73卷：961 - 967页。
Eur Urol. 2019 Mar;75(3):e54-e55. doi: 10.1016/j.eururo.2018.10.004. Epub 2018 Oct 12.
10
Re: Cathrine Alvær Vinje, Maria Nyre Vigmostad, Svein R. Kjosavik, Henrik Grönberg, Bjørnar Gilje, Svein Skeie. Prostate Biopsies Can Be Omitted in Most Patients with a Positive Stockholm3 Test and Negative Prostate Magnetic Resonance Imaging. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.08.009.
Eur Urol Focus. 2024 Mar;10(2):244-245. doi: 10.1016/j.euf.2023.11.016. Epub 2024 Jan 29.

本文引用的文献

1
Clinical performance of the 4Kscore Test to predict high-grade prostate cancer at biopsy: A meta-analysis of us and European clinical validation study results.4Kscore检测在活检时预测高级别前列腺癌的临床性能：对美国和欧洲临床验证研究结果的荟萃分析。
Rev Urol. 2017;19(3):149-155. doi: 10.3909/riu0776.
2
Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study.在ProtecT研究中，利用血液中检测的四种激肽释放酶标志物预测十芯前列腺活检中的高级别癌症。
J Natl Cancer Inst. 2015 Apr 11;107(7). doi: 10.1093/jnci/djv095. Print 2015 Jul.
3
Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer.用于预测前列腺癌的四激肽释放酶检测组合与前列腺健康指数的比较
Eur Urol. 2015 Jul;68(1):139-46. doi: 10.1016/j.eururo.2014.08.010. Epub 2014 Aug 20.

Re: Tobias Nordström, Andrew Vickers, Melissa Assel, Hans Lilja, Henrik Grönberg, Martin Eklund. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer. Eur Urol 2015;68:139-46.

作者信息

Vickers Andrew, Nordström Tobias, Assel Melissa, Lilja Hans, Grönberg Henrik, Eklund Martin

机构信息

Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

Department of Clinical Sciences, Danderyd's Hospital, Karolinska Institutet, Stockholm, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

出版信息

Eur Urol. 2018 Aug;74(2):e35-e36. doi: 10.1016/j.eururo.2018.04.027. Epub 2018 May 3.

DOI:10.1016/j.eururo.2018.04.027
PMID:29731258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6709856/
Abstract
摘要